FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3168049301> ?p ?o ?g. }

• W3168049301 abstract "The objective of this study was to investigate the effects of xylo-oligosaccharides (XOSs) supplementation on growth performance, serum parameters, small intestinal morphology, intestinal mucosal integrity, and immune function in weaned piglets. A total of 240 weaned piglets with an average body weight (BW) of 8.82 ± 0.05 kg (28 d of age) were assigned randomly to four dietary treatments in a 28-d trial, including a control (CON) diet and three diets with XOS supplementation at the concentration of 100 (XOS100), 500 (XOS500), and 1,000 (XOS1000) mg/kg. There were four replicates per treatment with 15 pigs per pen. From day 1 to 14, there were no differences (P > 0.05) in average daily gain (ADG), average daily feed intake, and gain to feed ratio (G:F) during the different treatments. The different doses of XOSs showed a quadratic effect on BW on day 28, ADG, and G:F on day 1 to 28 of piglets (P < 0.05). From day 15 to 28, ADG of pigs fed the XOS500 diet was higher (P < 0.05) than pigs fed the CON diet. During the overall period (day 1 to 28), pigs fed the XOS500 diet had a higher BW, ADG, and G:F than pigs fed the CON diet (P < 0.05). In addition, compared with the CON group, the XOS500 group had significantly higher serum total antioxidant capacity, total superoxide dismutase and catalase levels, and lower malondialdehyde levels on days 14 and 28 (P < 0.05). The serum immunoglobulin G (IgG) concentration in the XOS500 group was also significantly higher compared with the CON group on days 14 and 28 (P < 0.05). However, serum immunoglobulin A and immunoglobulin M were not affected by the dietary treatments. Supplementation of XOS500 to the feed significantly increased the villus height (VH) and VH to crypt depth ratio in the jejunum and ileum in comparison with the CON and XOS1000 groups. Moreover, the XOS500 group significantly elevated the expression levels of occludin and zonula occludens protein-1 in the ileum compared with the CON group. The ileal interleukin (IL)-1β, IL-8, and interferon (IFN)-γ mRNA expression levels in the XOS100 and XOS500 groups were markedly lower than in the CON group. In contrast, the ileal IL-10 mRNA expression levels were remarkably higher in the XOS500 than in the CON group. In conclusion, XOSs have a beneficial effect on growth performance by improving serum antioxidant defense system, serum IgG, small intestinal structure, and intestinal barrier function in weaned piglets." @default.
• W3168049301 created "2021-06-22" @default.
• W3168049301 creator A5000726024 @default.
• W3168049301 creator A5020147975 @default.
• W3168049301 creator A5031264125 @default.
• W3168049301 creator A5034332113 @default.
• W3168049301 creator A5040833719 @default.
• W3168049301 creator A5041708990 @default.
• W3168049301 creator A5057266545 @default.
• W3168049301 creator A5068801234 @default.
• W3168049301 creator A5079795759 @default.
• W3168049301 date "2021-06-07" @default.
• W3168049301 modified "2023-10-04" @default.
• W3168049301 title "Effects of graded levels of xylo-oligosaccharides on growth performance, serum parameters, intestinal morphology, and intestinal barrier function in weaned piglets" @default.
• W3168049301 cites W1049711197 @default.
• W3168049301 cites W1417385402 @default.
• W3168049301 cites W1934651558 @default.
• W3168049301 cites W1957210840 @default.
• W3168049301 cites W1968901326 @default.
• W3168049301 cites W1974991491 @default.
• W3168049301 cites W1980794946 @default.
• W3168049301 cites W1983754267 @default.
• W3168049301 cites W1997468521 @default.
• W3168049301 cites W2003537020 @default.
• W3168049301 cites W2005566483 @default.
• W3168049301 cites W2011814478 @default.
• W3168049301 cites W2023099428 @default.
• W3168049301 cites W2033898136 @default.
• W3168049301 cites W2074904804 @default.
• W3168049301 cites W2082256599 @default.
• W3168049301 cites W2093414109 @default.
• W3168049301 cites W2107277218 @default.
• W3168049301 cites W2129657560 @default.
• W3168049301 cites W2131336057 @default.
• W3168049301 cites W2192080449 @default.
• W3168049301 cites W2543595650 @default.
• W3168049301 cites W2753917252 @default.
• W3168049301 cites W2779350528 @default.
• W3168049301 cites W2790254840 @default.
• W3168049301 cites W2790362452 @default.
• W3168049301 cites W2801802973 @default.
• W3168049301 cites W2884868541 @default.
• W3168049301 cites W2888954507 @default.
• W3168049301 cites W2938439440 @default.
• W3168049301 cites W2944282973 @default.
• W3168049301 cites W2970640684 @default.
• W3168049301 cites W3135222165 @default.
• W3168049301 cites W4251734733 @default.
• W3168049301 cites W90152346 @default.
• W3168049301 doi "https://doi.org/10.1093/jas/skab183" @default.
• W3168049301 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8280928" @default.
• W3168049301 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34097723" @default.
• W3168049301 hasPublicationYear "2021" @default.
• W3168049301 type Work @default.
• W3168049301 sameAs 3168049301 @default.
• W3168049301 citedByCount "12" @default.
• W3168049301 countsByYear W31680493012021 @default.
• W3168049301 countsByYear W31680493012022 @default.
• W3168049301 countsByYear W31680493012023 @default.
• W3168049301 crossrefType "journal-article" @default.
• W3168049301 hasAuthorship W3168049301A5000726024 @default.
• W3168049301 hasAuthorship W3168049301A5020147975 @default.
• W3168049301 hasAuthorship W3168049301A5031264125 @default.
• W3168049301 hasAuthorship W3168049301A5034332113 @default.
• W3168049301 hasAuthorship W3168049301A5040833719 @default.
• W3168049301 hasAuthorship W3168049301A5041708990 @default.
• W3168049301 hasAuthorship W3168049301A5057266545 @default.
• W3168049301 hasAuthorship W3168049301A5068801234 @default.
• W3168049301 hasAuthorship W3168049301A5079795759 @default.
• W3168049301 hasBestOaLocation W31680493012 @default.
• W3168049301 hasConcept C134018914 @default.
• W3168049301 hasConcept C140793950 @default.
• W3168049301 hasConcept C147583825 @default.
• W3168049301 hasConcept C185592680 @default.
• W3168049301 hasConcept C22830521 @default.
• W3168049301 hasConcept C2775838275 @default.
• W3168049301 hasConcept C2777226302 @default.
• W3168049301 hasConcept C2778004101 @default.
• W3168049301 hasConcept C2778401633 @default.
• W3168049301 hasConcept C2778979269 @default.
• W3168049301 hasConcept C55493867 @default.
• W3168049301 hasConcept C86803240 @default.
• W3168049301 hasConceptScore W3168049301C134018914 @default.
• W3168049301 hasConceptScore W3168049301C140793950 @default.
• W3168049301 hasConceptScore W3168049301C147583825 @default.
• W3168049301 hasConceptScore W3168049301C185592680 @default.
• W3168049301 hasConceptScore W3168049301C22830521 @default.
• W3168049301 hasConceptScore W3168049301C2775838275 @default.
• W3168049301 hasConceptScore W3168049301C2777226302 @default.
• W3168049301 hasConceptScore W3168049301C2778004101 @default.
• W3168049301 hasConceptScore W3168049301C2778401633 @default.
• W3168049301 hasConceptScore W3168049301C2778979269 @default.
• W3168049301 hasConceptScore W3168049301C55493867 @default.
• W3168049301 hasConceptScore W3168049301C86803240 @default.
• W3168049301 hasFunder F4320321001 @default.
• W3168049301 hasFunder F4320335848 @default.
• W3168049301 hasIssue "7" @default.
• W3168049301 hasLocation W31680493011 @default.
• W3168049301 hasLocation W31680493012 @default.
• W3168049301 hasLocation W31680493013 @default.

• next